
12.95 Delayed Data As of Jun 28 | ![]() Today’s Change | 9.55 Today|||52-Week Range 35.73 | -46.02% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $533.0M |
Stoke Therapeutics, Inc. 45 Wiggins Avenue Bedford Massachusetts 01730 |
Edward M. Kaye | Chief Executive Officer & Director |
Huw M. Nash | Chief Operating & Business Officer |
Stephen J. Tulipano | Chief Financial Officer |
Barry S. Ticho | Chief Medical Officer |
Gene Liau | Chief Scientific Officer |